FDAFDA · Food and drugs·Recall number D-0166-2021
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01
Published December 9, 2020 · Recall initiated: November 25, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- ANAGRELIDE
- Manufacturer
- Torrent Pharma Inc
- Distributor
- Nationwide USA and Puerto Rico
- Lot
- Batch BFD1G001, exp 12/2021
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.